Alphatec (ATEC) Competitors

Haemonetics has higher revenue and earnings than Alphatec. Alphatec is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks.

Alphatec currently has a consensus target price of $17.40, suggesting a potential upside of 86.50%. Haemonetics has a consensus target price of $99.78, suggesting a potential downside of 2.81%. Given Alphatec's stronger consensus rating and higher probable upside, equities analysts clearly believe Alphatec is more favorable than Haemonetics.

Haemonetics has a net margin of 7.12% compared to Alphatec's net margin of -13.49%. Haemonetics' return on equity of 27.55% beat Alphatec's return on equity.

66.3% of Alphatec shares are owned by institutional investors. Comparatively, 99.7% of Haemonetics shares are owned by institutional investors. 13.5% of Alphatec shares are owned by insiders. Comparatively, 2.1% of Haemonetics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Haemonetics had 9 more articles in the media than Alphatec. MarketBeat recorded 9 mentions for Haemonetics and 0 mentions for Alphatec. Haemonetics' average media sentiment score of 1.36 beat Alphatec's score of 0.00 indicating that Haemonetics is being referred to more favorably in the news media.

Alphatec has a beta of 0.85, suggesting that its stock price is 15% less volatile than the broader market. Comparatively, Haemonetics has a beta of 0.54, suggesting that its stock price is 46% less volatile than the broader market.

66.3% of Alphatec shares are owned by institutional investors. Comparatively, 97.6% of LivaNova shares are owned by institutional investors. 13.5% of Alphatec shares are owned by insiders. Comparatively, 0.4% of LivaNova shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, LivaNova had 5 more articles in the media than Alphatec. MarketBeat recorded 5 mentions for LivaNova and 0 mentions for Alphatec. LivaNova's average media sentiment score of 0.88 beat Alphatec's score of 0.00 indicating that LivaNova is being referred to more favorably in the news media.

LivaNova has a net margin of 12.82% compared to Alphatec's net margin of -13.49%. LivaNova's return on equity of 16.35% beat Alphatec's return on equity.

Alphatec currently has a consensus target price of $17.40, indicating a potential upside of 86.50%. LivaNova has a consensus target price of $84.13, indicating a potential upside of 3.60%. Given Alphatec's stronger consensus rating and higher probable upside, research analysts clearly believe Alphatec is more favorable than LivaNova.

Alphatec has a beta of 0.85, indicating that its stock price is 15% less volatile than the broader market. Comparatively, LivaNova has a beta of 0.87, indicating that its stock price is 13% less volatile than the broader market.

Alphatec has higher earnings, but lower revenue than LivaNova. Alphatec is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks.

In the previous week, Integer had 11 more articles in the media than Alphatec. MarketBeat recorded 11 mentions for Integer and 0 mentions for Alphatec. Integer's average media sentiment score of 1.09 beat Alphatec's score of 0.00 indicating that Integer is being referred to more favorably in the news media.

Integer has higher revenue and earnings than Alphatec. Alphatec is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Integer has a net margin of 6.97% compared to Alphatec's net margin of -13.49%. Integer's return on equity of 12.79% beat Alphatec's return on equity.

66.3% of Alphatec shares are held by institutional investors. Comparatively, 99.3% of Integer shares are held by institutional investors. 13.5% of Alphatec shares are held by company insiders. Comparatively, 1.1% of Integer shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Alphatec has a beta of 0.85, suggesting that its share price is 15% less volatile than the broader market. Comparatively, Integer has a beta of 0.62, suggesting that its share price is 38% less volatile than the broader market.

Alphatec currently has a consensus target price of $17.40, suggesting a potential upside of 86.50%. Integer has a consensus target price of $109.86, suggesting a potential downside of 12.49%. Given Alphatec's stronger consensus rating and higher probable upside, equities research analysts plainly believe Alphatec is more favorable than Integer.

Alphatec presently has a consensus target price of $17.40, suggesting a potential upside of 86.50%. iRhythm Technologies has a consensus target price of $179.93, suggesting a potential upside of 45.77%. Given Alphatec's higher probable upside, equities analysts plainly believe Alphatec is more favorable than iRhythm Technologies.

iRhythm Technologies has lower revenue, but higher earnings than Alphatec. iRhythm Technologies is trading at a lower price-to-earnings ratio than Alphatec, indicating that it is currently the more affordable of the two stocks.

iRhythm Technologies has a net margin of -1.69% compared to Alphatec's net margin of -13.49%. iRhythm Technologies' return on equity of 10.11% beat Alphatec's return on equity.

Alphatec has a beta of 0.85, indicating that its stock price is 15% less volatile than the broader market. Comparatively, iRhythm Technologies has a beta of 1.31, indicating that its stock price is 31% more volatile than the broader market.

In the previous week, iRhythm Technologies had 2 more articles in the media than Alphatec. MarketBeat recorded 2 mentions for iRhythm Technologies and 0 mentions for Alphatec. iRhythm Technologies' average media sentiment score of 0.88 beat Alphatec's score of 0.00 indicating that iRhythm Technologies is being referred to more favorably in the news media.

66.3% of Alphatec shares are owned by institutional investors. 13.5% of Alphatec shares are owned by insiders. Comparatively, 1.0% of iRhythm Technologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.